z-logo
Premium
Contact sensitization to hydroperoxides of limonene and linalool: Results of consecutive patch testing and clinical relevance
Author(s) -
Dittmar Daan,
Schuttelaar Marie L. A.
Publication year - 2019
Publication title -
contact dermatitis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.524
H-Index - 96
eISSN - 1600-0536
pISSN - 0105-1873
DOI - 10.1111/cod.13137
Subject(s) - linalool , limonene , contact allergy , confidence interval , patch testing , allergic contact dermatitis , sensitization , patch test , medicine , clinical significance , demographics , dermatology , allergy , contact dermatitis , chemistry , food science , immunology , demography , sociology , essential oil
Background Hydroperoxides of limonene and linalool are potent sensitizers. Objectives To investigate the prevalence of contact allergy to both hydroperoxides of limonene and hydroperoxides of linalool, to report clinical relevance, and to investigate patient demographics. Methods A total of 821 patients (35.6% male, mean age 42.4 years ± 17.8 years) were consecutively patch tested with our departmental baseline series and our fragrance series, including hydroperoxides of limonene 0.3% pet. and hydroperoxides of linalool 1.0% pet. The clinical relevance was assessed for all positive reactions. Results Positive patch test reactions to hydroperoxides of limonene and to hydroperoxides of linalool were observed in 77 patients (9.4%, 95% confidence interval [CI]: 7.4%‐11.4%) and in 96 patients (11.7%, 95%CI: 9.5%‐13.9%), respectively; 38 of these patients (4.6%, 95%CI: 3.2%‐6.0%) reacted to both. Most reactions were considered to be possibly or probably clinically relevant (66.3% and 68.8%, respectively), and a small proportion were deemed to be of certain clinical relevance (18.2% and 19.8%, respectively). Conclusion As compared with previous studies, high numbers of positive reactions to both hydroperoxides of limonene and hydroperoxides of linalool were observed, the majority of which were clinically relevant, supporting their inclusion in the European baseline series.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here